| Code | CSB-RA011664MB8HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is designed as a research-grade biosimilar to Pacibekitug, targeting interleukin-6 (IL-6), a pleiotropic pro-inflammatory cytokine that plays a central role in immune regulation and inflammatory responses. IL-6 mediates its effects through both classical and trans-signaling pathways, influencing acute phase responses, B-cell differentiation, T-cell activation, and hematopoiesis. Dysregulated IL-6 signaling is implicated in numerous pathological conditions, including rheumatoid arthritis, cytokine release syndrome, inflammatory bowel disease, and various autoimmune disorders. Elevated IL-6 levels are also associated with certain malignancies and contribute to cancer-related inflammation and cachexia.
Pacibekitug is a humanized monoclonal antibody that binds to IL-6 with high specificity, neutralizing its biological activity by preventing receptor engagement. This biosimilar antibody provides researchers with a valuable tool for investigating IL-6-mediated signaling pathways, studying inflammatory disease mechanisms, and exploring potential therapeutic interventions in preclinical models. It enables detailed examination of IL-6's role in cytokine networks and immune cell communication across diverse experimental systems.
There are currently no reviews for this product.